Go to the list of all blogs
John Y White's Avatar
published in Blogs
Jul 31, 2026
Why Is Exxon Mobil (XOM) Stock Down -1.73% Today?

Why Is Exxon Mobil (XOM) Stock Down -1.73% Today?

Key Takeaways

  • Exxon Mobil shares fell approximately 1.73% in premarket trading Friday following the release of second-quarter 2026 earnings that narrowly missed Wall Street profit estimates.
  • Adjusted earnings came in at $3.52 per share, below the analyst consensus of $3.60, even as quarterly profit surged to a four-year high of $14.7 billion.
  • A Bank of America downgrade earlier in the week from Buy to Neutral added pressure, with the analyst citing limited upside after the stock's sharp rally.
  • Oil price volatility tied to the US-Iran conflict and uncertainty around Middle East production levels continue to weigh on sentiment.
  • The broader energy sector remains in focus as Chevron beat estimates, highlighting divergent performance among the integrated oil majors.
  • Investors are now watching for management's commentary on the earnings call regarding Middle East production restarts and the trajectory of shareholder returns.

Opening Summary

XOM, Exxon Mobil Corporation, the largest U.S. integrated oil and gas company by market capitalization with operations spanning upstream exploration, refining, chemicals, and lower-emission ventures, saw its stock decline approximately 1.73% in Friday trading. The move came after the company reported second-quarter 2026 adjusted earnings of $3.52 per share — a 67% sequential increase and more than double the year-ago figure — but just shy of the $3.60 Wall Street consensus. Shares retreated from Thursday's close of $156.97 to roughly $154.25 in the premarket session, as investors digested the rare earnings miss from an energy giant that nonetheless posted its highest quarterly profit in four years.

Earnings Miss Despite Record Profits

At first glance, Exxon Mobil's second-quarter results looked spectacular. Adjusted net income reached $14.7 billion, powered by Brent crude prices that averaged nearly $97 per barrel during the period amid the ongoing US-Iran conflict. Revenue surged 42% year-over-year to $116.02 billion, handily exceeding analyst forecasts of roughly $109.94 billion. Free cash flow swelled to $17.2 billion, funding $9.4 billion in shareholder distributions — $4.3 billion in dividends and $5.1 billion in share repurchases.

Yet the headline earnings per share of $3.52 fell below the LSEG-compiled consensus of $3.60, a miss of roughly eight cents. CFO Neil Hansen attributed the shortfall to "extreme swings" in commodity prices and refining margins that proved difficult for analysts to model accurately. Upstream production reached the highest level in more than two decades excluding Middle East disruptions, with record Permian Basin output exceeding 1.8 million barrels of oil equivalent per day. However, approximately 450,000 barrels per day of gas output in Qatar and another 150,000 barrels per day of crude in the UAE remained offline due to regional conflict, creating an unusual wedge between operational strength and reported results.

Bank of America Downgrade Adds Pressure

Compounding the earnings disappointment, Bank of America analyst Jean Ann Salisbury downgraded XOM from Buy to Neutral on Tuesday, July 28 — just three days before the earnings release. While Salisbury simultaneously raised the price target to $158 from $154, the downgrade acknowledged that the stock's nearly 15% rally from late June had largely exhausted the near-term upside case. The same analyst had upgraded Exxon to Buy on June 15 at around $136 per share.

The downgrade carried a pointed geopolitical dimension. Bank of America flagged that a potential Middle East ceasefire — which would likely push crude prices lower — poses asymmetric downside risk for Exxon relative to peers like CVX (Chevron), given that roughly 20% of Exxon's regional production remains offline. If hostilities subside and prices retreat, Exxon would face both lower realized crude prices and uncertain timelines for restoring shuttered volumes.

Oil Price Volatility and Geopolitical Crosswinds

The macro backdrop remains dominated by the US-Iran conflict, which has kept the Strait of Hormuz — a chokepoint for roughly one-fifth of global seaborne crude — under persistent threat. Oil prices experienced wild swings this week: Brent surged nearly 8% on Wednesday after renewed US-Saudi strikes against Iran-backed targets, only to ease Thursday as tanker traffic through the region continued despite heightened tensions. Brent traded around $90 per barrel and WTI near $84 on Friday morning, levels that remain highly supportive for upstream earnings but distinctly below the panic highs above $110 seen in April.

JPMorgan has estimated that each additional month of supply disruption could add $7 to $8 per barrel to Brent prices, while Goldman Sachs has cautioned that prices could spike to $120 under prolonged Strait of Hormuz disruption. For Exxon, this environment is a double-edged sword: high prices boost upstream revenues, but trapped production in the conflict zone limits the company's ability to fully capitalize.

Market Context and Trading Activity

The earnings-driven decline in XOM contrasted with peer CVX (Chevron), which beat analyst estimates and traded modestly higher. The divergence reflects growing differentiation among integrated majors based on their geographic exposure to Middle East disruption. Exxon's stock is still up roughly 28% year-to-date, roughly in line with the S&P 500 energy sector's 29% gain, but the stock has pulled back significantly from its 52-week high of $176.41. The shares sit below the $159.07 short-term entry level watched by technical traders and well below the average Wall Street price target of approximately $169.

Options markets had priced in a post-earnings move of roughly +/-2.32%, meaning Friday's decline falls within the expected range. Volume is likely to be elevated throughout the session as institutional investors adjust positions following the report.

What Comes Next for XOM

Attention now shifts to CEO Darren Woods' commentary on the earnings conference call, where investors will seek clarity on several critical issues. Foremost is the timeline for restarting offline Middle East production — about 600,000 barrels per day combined in Qatar and the UAE. Any credible path to restoring those volumes could recalibrate earnings models and potentially soften the stock's decline.

The company's capital allocation strategy remains a bright spot. With $17.2 billion in quarterly free cash flow and a $20 billion annual share repurchase program, Exxon's return-of-capital story is among the most robust in the S&P 500. The declared third-quarter dividend of $1.03 per share, payable September 10, marks the 43rd consecutive year of dividend growth. The fifth Guyana floating production vessel is on schedule for startup in the fourth quarter, adding 250,000 barrels per day of capacity. However, risks persist: a rapid diplomatic resolution to the Iran conflict could unwind the geopolitical premium in crude prices, while President Trump's renewed threats to investigate oil company pricing practices add a layer of political uncertainty.

Trending AI Robots

For traders seeking to navigate volatile markets like energy, Tickeron offers an extensive suite of AI-powered trading bots covering thousands of tickers across multiple strategies and timeframes. Only the strongest performers under current market conditions are featured in the curated Trending AI Robots section, where users can browse bots by strategy type, performance metrics, and traded symbols. Whether you follow momentum, value, or pattern-recognition approaches, this resource helps identify which algorithms are adapting best to today's fast-moving markets. Explore the Trending AI Robots page to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: XOM

Contributor

John Y White's AvatarJohn Y White|Beginner

XOM in upward trend: price rose above 50-day moving average on July 17, 2026

XOM moved above its 50-day moving average on July 17, 2026 date and that indicates a change from a downward trend to an upward trend. In of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on XOM as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XOM just turned positive on August 10, 2026. Looking at past instances where XOM's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for XOM crossed bullishly above the 50-day moving average on July 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOM advanced for three days, in of 367 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 316 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XOM moved out of overbought territory on July 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XOM broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 30, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.532) is normal, around the industry mean (2.214). P/E Ratio (20.560) is within average values for comparable stocks, (18.220). Projected Growth (PEG Ratio) (1.250) is also within normal values, averaging (1.251). Dividend Yield (0.025) settles around the average of (0.038) among similar stocks. P/S Ratio (1.869) is also within normal values, averaging (2.061).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 119.43B. The market cap for tickers in the group ranges from 39.76K to 656.88B. XOM holds the highest valuation in this group at 656.88B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 1%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 18%. SLNG experienced the highest price growth at 18%, while SKYQ experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -41% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 55
Price Growth Rating: 42
SMR Rating: 62
Profit Risk Rating: 29
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
XOM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a distributer of crude oil, natural gas and petroleum products

Industry IntegratedOil

Profile
Details
Industry
Integrated Oil
Address
22777 Springwoods Village Parkway
Phone
+1 972 940-6000
Employees
61500
Web
https://www.exxonmobil.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.